The table below shows Summit Therapeutics Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$0.00
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$132.62M
-
-
$51.27M
-
-
SG&A
SMMT annual revenue (10-K history)
Summit Therapeutics Inc. reported annual revenue of $0.00 for fiscal year 2024. Over the 8 fiscal years shown, annual revenue declined from $16.10M (FY 2018) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.
